Announcement Ticker
  99%+ PURITY · ANALYTICAL FORMULATIONS VERIFIED   FREE SHIPPING OVER $50 · 24HR DISPATCH   30+ RESEARCH COMPOUNDS IN STOCK   CERTIFICATE OF ANALYSIS ON EVERY LOT   99%+ PURITY · ANALYTICAL FORMULATIONS VERIFIED   FREE SHIPPING OVER $50 · 24HR DISPATCH   30+ RESEARCH COMPOUNDS IN STOCK   CERTIFICATE OF ANALYSIS ON EVERY LOT

Research Use Only: Intended for in-vitro laboratory research only. Not for human or animal consumption. This page provides mechanistic and research-context information only — it does not constitute dosing, administration, or medical advice of any kind.

Learn
›
Retatrutide
Metabolic Signaling

Retatrutide

A triple-agonist compound that activates GLP-1, GIP, and glucagon receptors.

Retatrutide is a synthetic single-chain peptide agonist of the GLP-1, GIP and glucagon receptors (tri-agonist), used as a reference material in incretin-receptor and metabolic-signaling research.

Activates 3 key metabolic receptors: GLP-1, GIP, and glucagon

Research shows stronger metabolic effects than single or dual-agonists

CAS 2381089-83-2

GLP-1 / GIP / glucagon receptor tri-agonist peptide

Scientific Mechanism

Receptor activation triggers downstream cAMP signaling that modulates insulin secretion, gastric emptying, and satiety signaling in in-vitro and animal models.

How It Works

Retatrutide activates three receptors simultaneously:

glp1:

GLP-1: receptor/pathway activity studied in in-vitro signaling models

gip:

GIP: receptor/pathway activity studied in in-vitro signaling models

glucagon:

Glucagon: receptor/pathway activity studied in in-vitro signaling models

What the Research Shows

Research Focus:

• Activates 3 key metabolic receptors: GLP-1, GIP, and glucagon
• Research shows stronger metabolic effects than single or dual-agonists
• CAS 2381089-83-2

Research Applications

Studied in in-vitro models for metabolic regulation, receptor pathway activation, and cellular energetics.

Key Research Points

  • Studied in in-vitro models for metabolic regulation, receptor pathway activation, and cellular energetics.
  • GLP-1 / GIP / glucagon receptor tri-agonist peptide (CAS 2381089-83-2)
  • Lot-level documentation and Certificate of Analysis

Common Questions

Unlike single-receptor compounds, Retatrutide works on three different pathways at once. Research suggests this multi-target approach may produce stronger and more comprehensive metabolic effects.
Store the sealed vial at -20 °C with desiccant, protected from light. After reconstitution, keep at 2–8 °C and discard after 28–30 days.
No. It is supplied strictly for in-vitro laboratory research and is not for human or animal consumption.

Research Considerations

  • For in-vitro laboratory research use only
  • Not for human or animal consumption
  • Verify identity and purity against the lot Certificate of Analysis
  • Handle with standard laboratory PPE and aseptic technique

Stability Protocol

Lyophilized powder: store at -20°C with desiccant, protected from light. Reconstituted solution: refrigerate at 2–8°C, discard after 28–30 days or if cloudiness/particulate appears.

Concentration Calculator

10
2
 

Concentration math only — for research reference. Not dosing guidance.

Certificate of Analysis

Purity
99%+
Method
HPLC / UV-Vis
Laboratory
Independent Laboratory

Research Use Only: Intended for in-vitro laboratory research only. Not for human or animal consumption. This page provides mechanistic and research-context information only — it does not constitute dosing, administration, or medical advice of any kind.

Researcher verification

Access is restricted to qualified researchers and institutions purchasing for in-vitro laboratory use only.

By proceeding you affirm the statements above are true. Products are supplied for in-vitro laboratory research only — not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.